Evidence map›Paper›PMID 38543072›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Dual Role of

Sanja Jelača, Ivan Jovanovic, Dijana Bovan, Marina Z Jovanovic, Milena M Jurisevic, Duško Dunđerović, Zora Dajic-Stevanovic, Nebojsa Arsenijevic, Sanja Mijatović, Danijela Maksimović-Ivanić

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Frontiers in pharmacology · 2025
    Article
  2. Antimelanoma Effects ofDiseases (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sanja JelačaDepartment of Immunology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.ORCID 0000-0002-9848-6859
Ivan JovanovicCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.ORCID 0000-0002-1169-2378
Dijana BovanDepartment of Immunology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.
Marina Z JovanovicDepartment of Otorhinolaryngology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Milena M JurisevicDepartment of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Duško DunđerovićInstitute of Pathology, School of Medicine, University of Belgrade, Dr Subotića 8, 11000 Belgrade, Serbia.ORCID 0000-0001-9708-2089
Zora Dajic-StevanovicFaculty of Agriculture, University of Belgrade, Nemanjina 6, 11080 Belgrade, Serbia.
Nebojsa ArsenijevicCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Sanja MijatovićDepartment of Immunology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.
Danijela Maksimović-IvanićDepartment of Immunology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.ORCID 0000-0002-8006-5079
University of Belgrade · RSUniversity of Kragujevac · RS

Funding

joint funding of Development and research projects of the Republic of Serbia and the People's Republic of China 06/2018Ministry of Science, Technological Development, and Innovation of the Republic of Serbia 451-03-47/2023-01/ 200007
6 · The paper itself

Abstract

Ethnomedicinal records have long mentioned the historical usage of

Indexed as

Alchemilla vulgaris L.apoptosisbreast cancerimmune responsetumor microenvironment

Identifiers

PMID38543072
PMCPMC10975144
OpenAlexW4392110324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.